Please see our news in the archive to the right.
MIOCA Awards $75,000 to Geri Fournier Ovarian Cancer Research Grant Recipients
March 30, 2016
Once again, MIOCA's Board of Directors has voted to award ovarian cancer researchers with funds to support their work here in Michigan.
Pam Dahlmann, MIOCA President, states, "We are extremely excited to triple the total provided to innovative researchers this year who are working on behalf of ovarian cancer patients. MIOCA is able to provide these grants because of the tremendous financial support we have received from our friends across the state."
MIOCA congratulates the 2016 Geri Fournier Research Grantees who are both working to address the issue of chemo resistance:
Ilana Chefetz Menaker, Ph.D $50,000
Research Assistant Professor
Internal Medicine, Division of Hematology/Oncology
University of Michigan Medical School
Characterization of the effect of ALDH1 isoform selective inhibitors in combination with MEK1/2 in ovarian cancer.
Karen McLean, M.D., Ph.D $25,000
Assistant Professor, Gynecologic Oncology
Translational Oncology Program
University of Michigan Health System
Inihibition of the DEK Oncoprotein in Xenogratfs Dervied from Ovarian Cancer
Strong Michigan presence at National Ovarian Cancer Advocacy Day in DC
March 3, 2016
Recently, eleven women gathered from Michigan for the Ovarian Cancer Research Fund Alliance's annual Advocacy Day on Capitol Hill. Representing several states across the country, ovarian cancer survivors, caregivers, researchers and others touched by ovarian cancer met with their members of Congress today to urge them to support critical research and educational programs.
Even if you couldn't attend, you can still make your voice heard by contacting Senator Stabenow, Senator Peters, and your US Representative. (Click here to find your rep. and to contact him/her.)
Ask Congress to fund the following ovarian cancer programs:
Strong federal funding for ovarian cancer research and education programs will allow us to build on prior investments in the search for better prevention, early detection, and treatment of ovarian cancer. Additionally, ask your representative to co-sponsor the Cancer Treatment Parity Act so that oral chemo is available at a cost no less favorable than IV administered or injected anticancer medications.
It is critical that your members of Congress hear from you! They are currently making decisions about how to spend federal money in 2017. As a constituent who has been touched by ovarian cancer, please take a few minutes TODAY to send a message to your legislators.